Privia Health Group, Inc. (PRVA)
NASDAQ (NGS) NASDAQ (NGS) Primary 
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two companies is the best option for those looking for undervalued stocks?
DH vs. PRVA: Which Stock Is the Better Value Option?
Investors with an interest in Medical Info Systems stocks have likely encountered both Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks presents investors with the better value opportunity right now?
DH vs. PRVA: Which Stock Should Value Investors Buy Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
DH or PRVA: Which Is the Better Value Stock Right Now?
Investors interested in Medical Info Systems stocks are likely familiar with Definitive Healthcare Corp. (DH) and Privia Health (PRVA). But which of these two stocks offers value investors a better bang for their buck right now?
Privia Health Group, Inc. (PRVA) Q3 2024 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q3 2024 Earnings Conference Call November 7, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President- Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants A.J. Rice - UBS Andrew Mok - Barclays Richard Close - Canaccord Genuity Jailendra Singh - Truist Securities Jamie Perse - Goldman Sachs Sameer Patel - Evercore ISI Matthew Gillmor - KeyBanc David Larsen - BTIG Jeff Garro - Stephens Ryan Langston - TD Cowen Daniel Grosslight - Citi Olivia Miles - Baird Jack Slevin - Jeffries Jessica Tassan - Piper Sandler Thomas Kelliher - RBC Capital Markets Adam Ron - Bank of America Operator Thank you for standing by.
Compared to Estimates, Privia Health (PRVA) Q3 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Privia Health (PRVA) give a sense of how the business performed in the quarter ended September 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Privia Health (PRVA) Misses Q3 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.06 per share. This compares to earnings of $0.05 per share a year ago.
Privia Health (PRVA) Earnings Expected to Grow: Should You Buy?
Privia Health (PRVA) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Privia Health Group, Inc. (PRVA) Q2 2024 Earnings Call Transcript
Privia Health Group, Inc. (NASDAQ:PRVA ) Q2 2024 Earnings Conference Call August 8, 2024 8:00 AM ET Company Participants Robert Borchert - Senior Vice President, Investor & Corporate Communications Parth Mehrotra - Chief Executive Officer David Mountcastle - Chief Financial Officer Conference Call Participants Josh Raskin - Nephron Research Andrew Mok - Barclays Eduardo Ron - Truist Securities Elizabeth Anderson - Evercore ISI A.J. Rice - UBS Jeff Garro - Stephens Jack Slevin - Jefferies David Larsen - BTIG Richard Close - Canaccord Genuity Jessica Tassan - Piper Sandler Ryan Daniels - William Blair Michael Hall - Baird Ryan Langston - TD Cowen Daniel Grosslight - Citi Adam Ron - Bank of America Operator Hello, and thank you for standing by.
Here's What Key Metrics Tell Us About Privia Health (PRVA) Q2 Earnings
Although the revenue and EPS for Privia Health (PRVA) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Privia Health (PRVA) Lags Q2 Earnings Estimates
Privia Health (PRVA) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.05 per share. This compares to earnings of $0.06 per share a year ago.
Earnings Preview: Privia Health (PRVA) Q2 Earnings Expected to Decline
Privia Health (PRVA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
